The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksUpdated•Originally published 18 April 2026•Updated 19 April 2026•

1 min read

Major Analyst Rating Changes for Tesla, Qualcomm, and Biogen

Portrait of Elon Musk over a golden world map showing Tesla cars, factories, and a red downward trend line.

Key Facts

1UBS upgraded Tesla, citing a more favorable risk-reward profile despite ongoing challenges.

2J.P. Morgan downgraded Qualcomm due to competitive pressures and macroeconomic concerns.

3Biogen's acquisition of Apellis is viewed positively as it provides new revenue streams to offset losses.

about 2 months ago

Version History

Version 1about 2 months ago

What changed: The story was updated to include the busy earnings week for S&P 500 firms, the Fed chair nominee hearing, and upcoming macroeconomic data points.

Major financial institutions have updated ratings for key tech players, with UBS upgrading Tesla and J.P. Morgan downgrading Qualcomm. This comes during a pivotal week as approximately 90 S&P 500 companies, including Tesla, Intel, and Boeing, are scheduled to report quarterly earnings. Market attention is also fixed on the political front, as Fed chair nominee Kevin Warsh is set to appear before the Senate Banking Committee. Furthermore, key economic indicators including pending home sales and Purchasing Managers' Index (PMI) data are expected to be released. These updates highlight a selective approach by analysts focusing on both company-specific catalysts and broader macroeconomic signals. Investors are closely monitoring these developments to reposition portfolios amidst ongoing market volatility.